Manulife (Manufacturers Life Insurance)
GALT icon

Manulife (Manufacturers Life Insurance)’s Galectin Therapeutics GALT Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio GALT Stock Details GALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-26,819
Closed -$72K – 3007
2020
Q3 		$72K Buy
26,819
+5,093
+23% +$14.3K ﹤0.01% 2861
2020
Q2 		$66K Sell
21,726
-8,552
-28% -$21.5K ﹤0.01% 2825
2020
Q1 		$59K Buy
30,278
+2,522
+9% +$6.14K ﹤0.01% 2709
2019
Q4 		$79K Buy
27,756
+1,493
+6% +$5.19K ﹤0.01% 2829
2019
Q3 		$95K Buy
26,263
+768
+3% +$2.78K ﹤0.01% 2833
2019
Q2 		$106K Buy
+25,495
New +$110K ﹤0.01% 2876
2018
Q3 		– Sell
-192
Closed -$1K – 3286
2018
Q2 		$1K Hold
192
– – ﹤0.01% 4249
2018
Q1 		$1K Buy
+192
New +$895 ﹤0.01% 4274
2017
Q2 		– Sell
-157
Closed – – 4388
2017
Q1 		$0 Hold
157
– – ﹤0.01% 4258
2016
Q4 		$0 Hold
157
– – ﹤0.01% 4386
2016
Q3 		$0 Hold
157
– – ﹤0.01% 4307
2016
Q2 		$0 Hold
157
– – ﹤0.01% 4277
2016
Q1 		$0 Hold
157
– – ﹤0.01% 4126
2015
Q4 		$0 Hold
157
– – ﹤0.01% 4036
2015
Q3 		$0 Hold
157
– – ﹤0.01% 4072
2015
Q2 		$0 Hold
157
– – ﹤0.01% 4040
2015
Q1 		$1 Hold
157
– – ﹤0.01% 3889
2014
Q4 		$1 Sell
157
-9,089
-98% -$40.2K ﹤0.01% 3831
2014
Q3 		$47 Sell
9,246
-2,650
-22% -$20.6K ﹤0.01% 3297
2014
Q2 		$164K Buy
11,896
+11,739
+7,477% +$146K ﹤0.01% 2874
2014
Q1 		$2 Hold
157
– – ﹤0.01% 3649
2013
Q4 		$1 Buy
+157
New +$1.45K ﹤0.01% 3735

Other funds holding GALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GWM
Geneos Wealth Management Englewood, Colorado $4.9B AUM 23.65% 1-Year Est. Return
CCB
Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s GALT Position: Q4 2020 in Review

Manulife (Manufacturers Life Insurance) sold out of Galectin Therapeutics (GALT) in Q4 2020, closing a stake of 26,819 shares — an estimated $72K sold.

Manulife (Manufacturers Life Insurance) first reported a position in GALT in Q4 2013 and held it in 22 quarters. The position peaked at $164K in Q2 2014. 78 funds tracked by Wall St. Rank hold GALT as of Q4 2020.

  • Manulife (Manufacturers Life Insurance) reported no remaining Galectin Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 26,819 Galectin Therapeutics shares in Q4 2020, an estimated $72K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Galectin Therapeutics in Q4 2013 and held it in 22 quarters.
  • Manulife (Manufacturers Life Insurance)'s Galectin Therapeutics position peaked at $164K in Q2 2014.
  • 78 funds tracked by Wall St. Rank held Galectin Therapeutics as of Q4 2020.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q4 2020, filed 12 Feb 2021.